• PIN55 RISK SCORES PREDICTING RESOURCE USE OF HEPATITIS C PATIENTS IN GERMANY-AN ANALYSIS OF SICK FUND CLAIMS DATA

    Nov 1, 2010, 00:00

  • PIN11 COSTS OF QUANTIFERON TB-GOLD VERSUS TUBERCULIN SKIN TEST IN SPANISH HEALTH CARE WORKERS

    Nov 1, 2010, 00:00

  • PMS47 COMPARISON OF DOSING PATTERNS BETWEEN FIBROMYALGIA PATIENTS WITH HIGH VERSUS LOW DULOXETINE OR PREGABALIN COMPLIANCE

    Nov 1, 2010, 00:00

  • PMS24 OSTEOPOROSIS COSTS IN ITALY. INTERIM RESULTS OF THE BLOCK STUDY

    Nov 1, 2010, 00:00

  • PIH64 A CONCEPTUAL FRAMEWORK FOR A PATIENT REPORTED OUTCOMES MEASURE OF ATTITUDES TOWARD COMPLEMENTARY AND ALTERNATIVE MEDICINE IN MENOPAUSE

    Nov 1, 2010, 00:00

  • PIH4 COMPARING THE MODEL PREDICTED VACCINE IMPACT AGAINST ROTAVIRUS HOSPITALIZATION WITH OBSERVED DATA IN BELGIUM

    Nov 1, 2010, 00:00

  • PHP60 HEALTH INSURANCE SUBSIDY OF SPA TREATMENT IN HUNGARY

    Nov 1, 2010, 00:00

  • PCN135 IMPROVEMENT IN QUALITY OF LIFE OUTCOMES IN INTERFERONALPHA TREATED PATIENTS COMPARED TO SUNITINIB IN ADVANCE OR METASTATIC RENAL CELL CARCINOMA

    Nov 1, 2010, 00:00

  • PMC57 BIAS IS WORSE THAN NOISE- HANDLING MISSING DATA FOR CONFOUNDERS IN OBSERVATIONAL STUDIES

    Nov 1, 2010, 00:00

  • PHP93 DOES THE PACKAGE DESIGN MATTER? THE INFLUENCE OF OTC PACKAGE DESIGN ON PATIENTS DRUG KNOWLEDGE

    Nov 1, 2010, 00:00

  • PHP38 HOW EQUITABLE OF HEALTH SERVICE USE AND GOVERNMENT SUBSIDIES IN THAILAND AFTER ACHIEVING UNIVERSAL COVERAGE?

    Nov 1, 2010, 00:00

  • PCN157 REASONS FOR DISCONTINUATION OF HORMONAL THERAPY IN BREAST CANCER PATIENTS ACROSS FIVE EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PCN117 UTILITY ELICITATION STUDY IN THE UK GENERAL PUBLIC FOR LATE STAGE CHRONIC LYMPHOCYTIC LEUKEMIA

    Nov 1, 2010, 00:00

  • PIN12 COST-OF-ILLNESS OF CHRONIC HEPATITIS B INFECTION IN VIETNAM

    Nov 1, 2010, 00:00

  • PCN109 COMPARISON OF HOSPITALIZATION BURDEN BETWEEN METASTATIC AND NON-METASTATIC MELANOMA PATIENTS IN A US POPULATION

    Nov 1, 2010, 00:00

  • PDB66 THE 8-ITEM MORISKY MEDICATION ADHERENCE SCALE MMAS- TRANSLATION AND VALIDATION STUDY OF THE MALAYSIAN VERSION

    Nov 1, 2010, 00:00

  • PMC20 THE OPTIMAL NUMBER OF MONTE CARLO SIMULATIONS TO BE PERFORMED IN PROBABILISTIC SENSITIVITY ANALYSIS- EMPIRICAL EVIDENCE FROM ECONOMIC MODELS CONSTRUCTED FOR SUBMISSION TO THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

    Nov 1, 2010, 00:00

  • PHP35 HEALTH TECHNOLOGY ASSESSMENTS- INDICATORS OF DEVELOPMENT IN ASIA

    Nov 1, 2010, 00:00

  • PHP97 TRAINING OF PHARMACEUTICAL SALES REPRESENTATIVES IN REGARD TO CHANGES IN HEALTH CARE POLICY IN GERMANY

    Nov 1, 2010, 00:00

  • PGI16 COST-EFFECTIVENESS OF ON-TREATMENT MONITORING OF HBSAG LEVELS TO PREDICT RESPONSE TO PEGINTERFERON-ALPHA-2A FOR HEPATITIS B TREATMENT UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL

    Nov 1, 2010, 00:00

  • PHP12 PHYSICIANS VIEWS ON BIOMEDICAL TECHNOLOGY IN GREECE

    Nov 1, 2010, 00:00

  • PIN75 ESTIMATION OF PATIENTS WITH ANTIRETROVIRAL THERAPY POTENTIALLY USED FOR HIV PREVENTION (POST-EXPOSURE PROPHYLAXIS, MOTHER-TO-CHILD TRANSMISSION PROPHYLAXIS) IN GERMANY

    Nov 1, 2010, 00:00

  • PMH65 EFFECTIVENESS OF PHARMACEUTICAL THERAPY OF ADHD (ATTENTION-DEFICIT/HYPERACTIVITY DISORDER) IN ADULTS-A HEALTH TECHNOLOGY ASSESSMENT

    Nov 1, 2010, 00:00

  • PDB38 ADDITION OF INCRETIN-THERAPY TO METFORMIN IN TYPE-2DIABETES MELLITUS (T2DM)- COST-EFFECTIVENESS OF LIRAGLUTIDE VERSUS SITAGLIPTIN FROM THE PERSPECTIVE OF THE GERMAN STATUTORY HEALTH INSURANCE (SHI)

    Nov 1, 2010, 00:00

  • PMC32 MINIMALLY IMPORTANT DIFFERENCE OF THE TREATMENT SATISFACTION WITH MEDICINES QUESTIONNAIRE (SATMED-Q)

    Nov 1, 2010, 00:00

  • PCN60 CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH ADJUVANT CHEMOTHERAPY IN ELDERLY PATIENTS WITH EARLY STAGE OPERABLE BREAST CANCER

    Nov 1, 2010, 00:00

  • PMC29 USING DOZENS OF ATTRIBUTES WITHOUT INCREASING RESPONDENT BURDEN- HOW TO ADAPT LATENT VARIABLE MODELING FOR LINKING ATTRIBUTES ON SEPARATE CONJOINT SURVEYS

    Nov 1, 2010, 00:00

  • PCV112 QUALITY OF LIFE AND DEPRESSION AMONG ADULTS WITH TYPE 2 DIABETES MELLITUS, HYPERTENSION, AND OBESITY

    Nov 1, 2010, 00:00

  • PMS68 PHYSICIANS STATED PREFERENCES OVER BENEFITS AND RISKS ASSOCIATED WITH NSAID USE IN PATIENTS WITH OSTEOARTHRITIS IN UNITED KINGDOM

    Nov 1, 2010, 00:00

  • PMC7 TRANSLATING ITEM BANKS- BENEFITS AND CHALLENGES

    Nov 1, 2010, 00:00

  • PCV24 AN EPIDEMIOLOGICAL EVALUATION OF THE IMPACT OF PERCUTANEOUS CORONARY INTERVENTIONS ON THE LENGTH OF STAY AND MORTALITY OF PATIENTS HOSPITALIZED WITH ACUTE CORONARY SYNDROMES

    Nov 1, 2010, 00:00

  • PMH59 EVALUATION OF THE EFFECT OF ARIPIPRAZOLE ON QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA IN A PROSPECTIVE, MULTICENTRE, OPEN-LABEL STUDY

    Nov 1, 2010, 00:00

  • PSY18 DIRECT MEDICAL COSTS OF LIQUID INTRAVENOUS IMMUNOGLOBULINS IN CHILDREN, ADOLESCENTS AND ADULTS IN SPAIN

    Nov 1, 2010, 00:00

  • PMS20 COST AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SOUTH KOREA

    Nov 1, 2010, 00:00

  • PHP22 THE USE OF ECONOMIC EVALUATIONS IN DECISION-MAKING AT MACRO LEVEL- A LITERATURE REVIEW

    Nov 1, 2010, 00:00

  • PHP46 COSTS OF TREATING TERMINAL PATIENTS IN DIFFERENT BELGIAN HEALTH CARE SETTINGS

    Nov 1, 2010, 00:00

  • PUK25 USING GENETIC POLYMORPHISM AS A STRATEGY TO ESTIMATE THE POTENTIAL COST-EFFECTIVENESS OF PHARMACOLOGICAL CCR5 BLOCKADE IN DIALYSIS PATIENTS

    Nov 1, 2010, 00:00

  • PCN75 COMPARISON OF ADVANCED NONINVASIVE TECHNIQUES TO SCREEN COLORECTAL CANCER- FECAL IMMUNOCHEMICAL TEST VS. FECAL DNA; A COS-EFFECTIVENESS STUDY

    Nov 1, 2010, 00:00

  • PND31 IMPACT OF AN ADHERENCE PROGRAM, RUN AS A TELEPHONE INTERVENTION ON COMPLIANCE WITH SUBCUTANEOUS INTERFERON -1A FOR MULTIPLE SCLEROSIS PATIENTS USING A MAIL-ORDER PHARMACY

    Nov 1, 2010, 00:00

  • PSS10 CLINICAL AND COST-EFFECTIVENESS EVALUATION OF A LOW FRICTION AND SHEAR PRODUCT IN THE MANAGEMENT OF PATIENTS AT RISK OF SKIN BREAKDOWN WITHIN A HOSPITAL SETTING

    Nov 1, 2010, 00:00

  • PMH67 FACTORS ASSOCIATED WITH ANTIPSYCHOTICS USE AMONG COMMUNITY-DWELLING OLDER PERSONS WITH DEMENTIA

    Nov 1, 2010, 00:00

  • PDB40 THE ECONOMIC IMPORTANCE OF 'METABOLIC MEMORY' IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN SWEDEN

    Nov 1, 2010, 00:00

  • PMC11 ARE THRESHOLD RANGES FOR COST PER QALY A BARRIER TO RESEARCH FOR LIFE EXTENDING TREATMENTS

    Nov 1, 2010, 00:00

  • PSY34 COST-EFFECTIVENESS OF TAPENTADOL PROLONGED-RELEASE (PR) COMPARED TO OXYCODONE AND MORPHINE IN PATIENTS WITH CHRONIC MODERATE TO SEVERE NON-CANCER PAIN IN SWEDEN

    Nov 1, 2010, 00:00

  • PCV58 SUBSTITUTION INFLUENCE FROM MARK DRUGS TO GENERICS IN THE ARTERIAL HYPERTENSION THERAPEUTIC COMPLIANCE AND THE DYSLIPEMIA IN A POPULATION SETTING

    Nov 1, 2010, 00:00

  • PDB80 A CONTROLLED, PROSPECTIVE LONGITUDINAL, INTERVENTIONAL, NATURALISTIC STUDY TO EVALUATE THE UNIQUE HEALTH CARE PROGRAM 'CONVERSATION MAP' FOR TURKISH PATIENTS WITH TYPE-2 DIABETES IN ONE GERMAN MAJOR CITY

    Nov 1, 2010, 00:00

  • PCV48 ST. VINCENTS PRIVATE HOSPITAL VENOUS THROMBOEMBOLISM PREVENTION PROJECT- ANALYSIS OF REDUCED COST AND IMPROVED CLINICAL OUTCOMES

    Nov 1, 2010, 00:00

  • PMS18 A BUDGET IMPACT MODEL FOR THE ECONOMIC ASSESSMENT OF TOCILIZUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS IN ITALY

    Nov 1, 2010, 00:00

  • PCN149 DECIDING UPON NEW AND EXPENSIVE TECHNOLOGIES IN HEALTH CARE- REAL OPTIONS ANALYSIS IN PROTON THERAPY

    Nov 1, 2010, 00:00

  • PDB32 COST-EFFECTIVENESS CONSEQUENCES OF OBESITY IN T2DM BY INSULIN ANALOGUE THERAPY

    Nov 1, 2010, 00:00

  • PCN17 NO CONCLUSIVE EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS (RCTS) FOR IMPROVED SURVIVAL WITH SECOND-LINE TREATMENT OPTIONS, IN PATIENTS WITH METASTATIC HORMONEREFRACTORY PROSTATE CANCER (MHRPC) PREVIOUSLY TREATED WITH DOCETAXEL

    Nov 1, 2010, 00:00

  • PUK24 A COST-UTILITY ANALYSIS OF CINACALCET IN SECONDARY HYPERPARATHYROIDISM (SHPT) IN FIVE EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PCN16 MIXED TREATMENT COMPARISON OF BEVACIZUMAB-BASED THERAPIES RELATIVE TO DOUBLET-CHEMOTHERAPY COMBINATIONS TO ESTIMATE THE RELATIVE EFFICACY IN PROGRESSION-FREE SURVIVAL FOR TREATMENT OF FIRST-LINE ADVANCED OR METASTATIC NON-SMALL CELL L ...

    Nov 1, 2010, 00:00

  • PIH39 PATIENTS WITH URINARY DISORDERS, EVOCATIVE OF BPH WHAT ARE THEIR EXPECTATIONS?

    Nov 1, 2010, 00:00

  • PHP8 INTERVENTIONS TO REDUCE HOSPITAL READMISSIONS IN THE ELDERLY

    Nov 1, 2010, 00:00

  • PHP75 EVALUATION OF THE IMPACT OF INPATIENT CLINICAL PHARMACY SERVICES ON THE QUALITY AND COST OF PHARMACOTHERAPY IN INTERNAL MEDICINE WARDS

    Nov 1, 2010, 00:00

  • PMC21 USING GROWTH IN THE COST-EFFECTIVENESS THRESHOLD TO INFORM THE DIFFERENTIAL BETWEEN THE DISCOUNT RATES ON COSTS AND HEALTH EFFECTS- REASON TO BE CAUTIOUS?

    Nov 1, 2010, 00:00

  • PCV13 META REGRESSION ANALYSIS TO INDIRECTLY COMPARE THE SAFETY AND EFFICACY OF DALTEPARIN TO ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS (VTES) IN TOTAL HIP REPLACEMENT (THR) SURGERY

    Nov 1, 2010, 00:00

  • PIN24 PATTERNS OF ANTIMICROBIAL DRUG USE IN INDIAN INTENSIVE CARE UNIT SETTINGS

    Nov 1, 2010, 00:00

  • PMC46 TRANSLATION AND LINGUISTIC VALIDATION OF PRO MEASURES- RESPONSE OPTION ISSUES

    Nov 1, 2010, 00:00

  • PSY10 CHARACTERIZATION OF TREATMENT STRATEGIES FOR NEUROPATHIC PAIN- EVIDENCE FROM A PAIN SPECIALIST SETTING IN THAILAND

    Nov 1, 2010, 00:00

  • PGI5 EVALUATION OF OCTREOTIDE COST AFTER PHARMACEUTICAL CARE IMPLEMENTATION AT SURGICAL WARD

    Nov 1, 2010, 00:00

  • PIH9 COST COMPARISON OF MIDWIFE-LED VERSUS OTHER MODELS OF CARE FOR CHILDBEARING WOMEN FROM THE PRIVATE PAYER PERSPECTIVE IN BRAZIL

    Nov 1, 2010, 00:00

  • PSS32 THE EXPERIENCE OF EXTERNAL GENITAL WARTS AND GENITAL HERPES ON QUALITY OF LIFE

    Nov 1, 2010, 00:00

  • PRS38 SYMPTOMATIC COMORBIDITIES AND HEALTH-RELATED QUALITY OF LIFE IN COPD IN THE EUROPEAN UNION

    Nov 1, 2010, 00:00

  • PCV10 ANALYSIS OF INAPPROPRIATE SHOCKS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DEVICES

    Nov 1, 2010, 00:00

  • PCN26 ESTIMATION OF THE EPIDEMIOLOGICAL EFFECT OF RITUXIMAB FOR THE TREATMENT OF AGGRESSIVE NON-HODGKIN LYMPHOMA

    Nov 1, 2010, 00:00

  • PCV18 COMPARISON OF MIXED DYSLIPIDEMIAS AMONG HIGH CARDIOVASCULAR RISK PRIMARY CARE PATIENTS- RESULTS OF A POOLED ANALYSIS OF PRIMULA DATA FROM CANADA, SPAIN, SWEDEN, AND THE UNITED KINGDOM

    Nov 1, 2010, 00:00

  • PCN102 COST-EFFECTIVENESS OF DIGITAL MAMMOGRAPHY IN A BREAST CANCER POPULATION-BASED SCREENING PROGRAM

    Nov 1, 2010, 00:00

  • PMC1 SURVIVAL ANALYSIS WITH COX REGRESSION MODELS-VALIDATING A WEB-BASED CALCULATOR

    Nov 1, 2010, 00:00

  • PSY27 A HEALTH ECONOMIC EVALUATION OF THE SWITCH OF ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN PATIENTS WITH RENAL FAILURE UNDERGOING HEMODIALYSIS

    Nov 1, 2010, 00:00

  • PIN58 REPORT ON A PILOT STUDY OF THE SIMPILL REALTIME MEDICATION ADHERENCE SYSTEM IN TUBERCULOSIS PATIENTS IN CAPE TOWN, SOUTH AFRICA

    Nov 1, 2010, 00:00

  • PIH10 COST-EFECTIVENESS OF QUADRIVALENT AND BIVALENT HPV VACCINATIONS AGAINST CERVICAL CANCER

    Nov 1, 2010, 00:00

  • PCN61 COST IMPACT OF ORAL CAPECITABINE COMPARED TO 5-FLUOROURACIL FOR TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER

    Nov 1, 2010, 00:00

  • PCN120 UTILITY AND WORK PRODUCTIVITY DATA FOR ECONOMIC EVALUATION OF BREAST CANCER THERAPIES IN THE NETHERLANDS AND SWEDEN

    Nov 1, 2010, 00:00

  • PIH13 PATTERNS AND COSTS OF HOSPITALIZATIONS IN ELDERLY PATIENTS IN RIO DE JANEIRO, BRAZIL

    Nov 1, 2010, 00:00

  • PHP5 THE ESSENTIAL MEDICINE SYSTEM IN CHINA- STRATEGIES AND CHALLENGES

    Nov 1, 2010, 00:00

  • PMC4 CHOOSING THE RIGHT DISTRIBUTION WHEN PERFORMING PROBABILISTIC SENSITIVITY ANALYSIS- RELATIVE RISKS AND THE TRIANGULAR DISTRIBUTION A SIMULATION STUDY

    Nov 1, 2010, 00:00

  • PIH28 DETERMINANTS OF HEALTH SERVICE UTILIZATION FOLLOWING THE 2004 TSUNAMI IN THAILAND

    Nov 1, 2010, 00:00

  • PDB79 DURATION OF FIRST INSULIN THERAPY IN PREVIOUSLY UNCONTROLLED TYPE 2 DIABETES- COMPARISON OF INSULINS GLARGINE, DETEMIR AND NPH AND ASSOCIATION WITH GLYCEMIC CONTROL

    Nov 1, 2010, 00:00

  • PCV41 ANTI-THROMBOLYTIC AGENT USE AND PATTERNS OF HEALTH-CARE UTILIZATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (AMI) USING KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASE

    Nov 1, 2010, 00:00

  • PMH6 INCREASING ADMINISTRATIVE PREVALENCE OF ATTENTION-DEFICIT/ HYPERACTIVITY DISORDER (ADHD) IN GERMANY- EVIDENCE FROM NORDBADEN, 2003 TO 2008

    Nov 1, 2010, 00:00

  • CN1 CERVICAL CANCER SCREENING PROGRAM IN THAILAND- ASSESSMENT OF SERVICE COVERAGE AND DETERMINANTS OF PROGRAM UPTAKE

    Nov 1, 2010, 00:00

  • PDB34 THE ECONOMIC VALUE OF THE EASYPOD ELECTRONIC AUTOINJECTOR IN IMPROVING THE RESPONSE TO GROWTH HORMONE (GH) IN CHILDREN WITH IDIOPATHIC GROWTH HORMONE DEFICIENCY (IGHD)- A COST-CONSEQUENCE ANALYSIS

    Nov 1, 2010, 00:00

  • PMH62 TRENDS IN ANTIDEPRESSANTS AND ANXIOLYTICS DRUG USAGE IN CROATIA AND SLOVENIA

    Nov 1, 2010, 00:00

  • PMS23 BURDEN OF ILLNESS OF OSTEOPOROSIS IN AUSTRIA

    Nov 1, 2010, 00:00

  • PMS31 THE IMPACT OF CHANGES IN ADALIMUMAB, ETANERCEPT, AND INFLIXIMAB DOSES ON THE COSTS OF TREATING RHEUMATOID ARTHRITIS

    Nov 1, 2010, 00:00

  • PRS22 COST OF COPD IN POLAND

    Nov 1, 2010, 00:00

  • DU2 THE UTILIZATION OF PROPHYLACTIC ANTITHROMBOTIC AGENTS AFTER MAJOR ORTHOPEDIC SURGERIES-A POPULATION-BASED STUDY IN TAIWAN

    Nov 1, 2010, 00:00

  • PMS15 FREQUENCY AND RISK FACTORS OF GOUT FLARES IN A LARGE POPULATION-BASED COHORT OF INCIDENT GOUT

    Nov 1, 2010, 00:00

  • PCV79 COST-EFFECTIVENESS OF DRONEDARONE IN SOUTH KOREA

    Nov 1, 2010, 00:00

  • PMS45 PRODUCTIVITY COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SOUTH KOREA

    Nov 1, 2010, 00:00

  • PMS6 COMPARISON OF RECENTLY REGISTERED BIOLOGICAL DRUGS WITH AVAILABLE THERAPIES IN RHEUMATOID ARTHRITIS- METHODOLOGICAL ISSUES TO CONSIDER FOR META-ANALYSIS

    Nov 1, 2010, 00:00

  • PMH12 COST-EFFECTIVENESS OF TYPICALS, ATYPICALS AND PSYCHOSOCIAL INTERVENTIONS FOR SCHIZOPHRENIA IN THAILAND

    Nov 1, 2010, 00:00

  • PDB72 FURTHER DEVELOPMENTS OF THE QUALITY OF LIFE ASSESSMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS (QOL-AGHDA)

    Nov 1, 2010, 00:00

  • HT1 EARLY ALERT SYSTEMS FOR NEW PHARMACEUTICALS-DO THEY HAVE AN IMPACT ON PHARMACEUTICAL REIMBURSEMENT DECISIONS?- A CROSS-NATIONAL COMPARISON

    Nov 1, 2010, 00:00

  • PSS27 COSMETI QOL-A TOOL FOR ASSESSING QUALITY OF LIFE IN COSMETIC DERMATOLOGY

    Nov 1, 2010, 00:00

  • PDB30 USE OF MEDICAL INFORMATION SYSTEM FOR ASSESSMENT OF THE COST OF THERAPY OF DIABETIC FOOT PATIENTS IN RUSSIA

    Nov 1, 2010, 00:00

  • PMC43 DATA POOLING OF PATIENT-REPORTED OUTCOMES IN CLINICAL TRIALS- EVALUATION OF STATISTICAL TECHNIQUES FOR ASSESSING MEASUREMENT EQUIVALENCE

    Nov 1, 2010, 00:00

  • DS4 HERBAL PRODUCTS SAFETY- AN APPLICATION OF HEALTH PRODUCT VIGILANCE CENTER DATABASE

    Nov 1, 2010, 00:00

  • PMH58 MODELING PROGRESSION IN DEMENTIA- ASSESSING THE PERFORMANCE OF FIVE CLINICAL MEASURES IN SPANISH SUBJECTS AND CAREGIVERS

    Nov 1, 2010, 00:00

  • PMH49 ANTIDEPRESSANT UTILIZATION, ADHERENCE AND HEALTH CARE SPENDING IN THE UNITED STATES-THE CASE OF MDD PATIENTS 2000-2007

    Nov 1, 2010, 00:00

  • PCV3 MIXED TREATMENT COMPARISON OF PROPHYLAXIS REGIMENS FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL HIP REPLACEMENT, HIP FRACTURE, TOTAL KNEE REPLACEMENT AND GENERAL SURGERY

    Nov 1, 2010, 00:00

  • PDB23 THE EFFECT OF METFORMIN BRAND SHIFT BY HOSPITAL ON DIABETIC TREATMENT OUTCOMES

    Nov 1, 2010, 00:00

  • PIH26 DEVELOPMENT OF A SEGMENTATION MODEL TO IDENTIFY HEALTH CARE DEMAND AND RELATED COSTS ATTRIBUTABLE TO POPULATIONS CHARACTERISTICS

    Nov 1, 2010, 00:00

  • PCV101 THE IMPACT OF MEDICATION SWITCHES INDUCES BY MEDICATION DISCOUNT CONTRACTS ON CHRONIC PATIENTS ADHERENCE

    Nov 1, 2010, 00:00

  • PCV17 RESPONSE PROFILES OF SILDENAFIL CITRATE ON EXERCISE CAPACITY, HEMODYNAMIC FUNCTION, AND HEALTH-RELATED QUALITY OF LIFE IN CHILDREN WITH PULMONARY ARTERIAL HYPERTENSION

    Nov 1, 2010, 00:00

  • PHP62 VALUE OF CONGRESS ABSTRACTS OF COST-EFFECTIVENESS STUDIES FOR DECISION MAKERS

    Nov 1, 2010, 00:00

  • PIH35 DETERMINATION OF COMMUNITY PHARMACYS DISPENSING COST IN MALAYSIA

    Nov 1, 2010, 00:00

  • PHP48 ECONOMIC EVALUATION OF HEALTH CARE INTERVENTIONS DURING MORE THAN 25 YEARS IN SPAIN (1983-2008)

    Nov 1, 2010, 00:00

  • HT2 INFLUENCE OF HTA AND HOSPITAL FUNDING SYSTEMS ON PATIENT ACCESS TO INNOVATIVE MEDICINES- EXAMPLE OF ADVANCED RENAL CELL CANCER IN WESTERN EUROPE

    Nov 1, 2010, 00:00

  • PIN2 ESTIMATED IMPACT OF SUSTAINED VIROLOGICAL RESPONSE (SVR) ON LIFE EXPECTANCY, QUALITY-ADJUSTED LIFE-YEARS (QALYS) AND LIFETIME COSTS IN CHRONIC HEPATITIS C (CHC) PATIENTS

    Nov 1, 2010, 00:00

  • PND37 PATIENT AND PHYSICIAN GLOBAL PERCEPTION OF LEVODOPA/ CARBIDOPA/ENTACAPONE VS. LEVODOPA/CARBIDOPA IN PATIENTS WITH PARKINSONS DISEASE EXPERIENCING EARLY WEARING-OFF

    Nov 1, 2010, 00:00

  • PMH4 LABOR FORCE WITHDRAWAL OF PATIENTS WITH PSYCHIATRIC ILLNESS IN TAIWAN

    Nov 1, 2010, 00:00

  • PSS21 AN ECONOMIC ANALYSIS OF TACROLIMUS OINTMENT MAINTENANCE USE (TWICE WEEKLY) VERSUS STANDARD USE IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS IN NORWAY AND FINLAND

    Nov 1, 2010, 00:00

  • PRS5 BUDESONIDE/FORMOTEROL PLUS TIOTROPIUM (BUD/FORM TIO)- A SYSTEMATIC REVIEW AND ADJUSTED INDIRECT COMPARISON BETWEEN TWO ALTERNATIVE TRIPLE TREATMENTS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

    Nov 1, 2010, 00:00

  • PHP16 A COMPREHENSIVE STUDY OF GENERIC DRUG ENTRY IN THE UNITED STATES- 1991-2008

    Nov 1, 2010, 00:00

  • PIH25 THE IMPACT OF EMPLOYEES WORK ABSENTEEISM DUE TO CARE FOR A SICK PERSON ON PRODUCTIVITY IN POLAND

    Nov 1, 2010, 00:00

  • PHP30 MARKET ACCESS, AFFORDABILITY AND PRICE COMPONENTS OF MEDICINES IN THE UNITED ARAB EMIRATES (UAE)

    Nov 1, 2010, 00:00

  • PHP127 ADOPTING A FINANCIAL RISK-SHARING SCHEME FOR NEW TECHNOLOGIES ADDED TO THE NATIONAL LIST OF HEALTH SERVICES IN ISRAEL- STAKEHOLDERS STATED INCENTIVES AND DISINCENTIVES

    Nov 1, 2010, 00:00

  • PCV33 ESTIMATING THE FINANCIAL IMPLICATIONS TO THE UK NHS OF INTRODUCING COREVALVE ALONGSIDE MEDICAL MANAGEMENT FOR THE TREATMENT OF SEVERE AORTIC STENOSIS

    Nov 1, 2010, 00:00

  • PIN9 ESTIMATED HEALTH AND ECONOMIC IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN JAPAN USING A TRANSMISSION DYNAMIC MODEL

    Nov 1, 2010, 00:00

  • PIN2 SURGICAL SITE INFECTION IN INDIA- A SYSTEMATIC REVIEW OF THE INCIDENCE AND ECONOMIC BURDEN

    Nov 1, 2010, 00:00

  • PMC1 BEST PRACTICES IN REPORTING OF PROSPECTIVE OBSERVATIONAL STUDIES

    Nov 1, 2010, 00:00

  • PMC58 SYSTEMATIC REVIEW OF STATISTICAL METHODS OF META-ANALYSIS AND INDIRECT COMPARISON POTENTIALLY AVAILABLE TO USE IN SYSTEMATIC REVIEWS-RESULTS FROM THE FIRST PART OF EBAYESMET PROJECT

    Nov 1, 2010, 00:00

  • PMH32 ECONOMIC EVALUATION OF AGOMELATINE IN MAJOR DEPRESIVE DISORDERS IN HUNGARY

    Nov 1, 2010, 00:00

  • PSS23 THE USE AND MISUSE OF ANTIBIOTICS FOR UPPER RESPIRATORY TRACT INFECTION

    Nov 1, 2010, 00:00

  • PCN55 COST OF TREATMENT OF BREAST CANCER IN RUSSIA

    Nov 1, 2010, 00:00

  • PIN8 COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON (ALFA-2B) WITH RIBAVIRIN COMPARED WITH PEGINTERFERON (ALFA-2A) WITH RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C

    Nov 1, 2010, 00:00

  • PDB22 EVALUATION OF ANTIDIABETIC UTILIZATION AND PRESCRBING PATTERNS IN TAIWAN DURING 2004 TO 2008

    Nov 1, 2010, 00:00

  • PCV106 THE MISSING PIECE BETWEEN TREATMENT EXPERIENCE AND INTENTION TO PERSIST-TESTING THE INTERNAL CONSISTENCY RELIABILITY AND PREDICTIVE VALIDITY OF ACCEPTABILITY

    Nov 1, 2010, 00:00

  • PHP45 COSTS OF CARE UNDER A HEALTH CARE PLAN IN THE LAST 5 YEARS OF LIFE OF BENEFICIARIES-DATA FROM THE REAL WORLD

    Nov 1, 2010, 00:00

  • PCN78 OST-EFFECTIVENESS ANALYSIS OF ADJUVANT THERAPY WITH IMATINIB MESYLATE IN PATIENTS AFTER RESECTION OF LOCALIZED PRIMARY GASTROINTESTINAL STROMAL TUMOR

    Nov 1, 2010, 00:00

  • PHP117 EMERGENCY NURSES AND PHYSICAL EXAMINATIONS-WHOSE DUTY?

    Nov 1, 2010, 00:00

  • PMS26 HIP FRACTURES IN THE ELDERLY- COST OF ILLNESS STUDY UNDER A PUBLIC HOSPITAL PERSPECTIVE IN RIO DE JANEIRO, BRAZIL

    Nov 1, 2010, 00:00

  • PDB27 INDIRECT COSTS OF ILLNESS FOR DIABETES IN PORTUGAL

    Nov 1, 2010, 00:00

  • PHP119 ROLE OF QUALITY IMPROVEMENT FOR MANAGEMENT OF SURGICAL BLEED COMPLICATIONS (SBCS)

    Nov 1, 2010, 00:00

  • PND41 THE IMPACT OF PAIN SEVERITY AND FREQUENCY ON HRQOL IN THE BIG 5 EUROPEAN UNION COUNTRIES

    Nov 1, 2010, 00:00

  • PMS37 THE COST-EFFECTIVENESS OF ABATACEPT IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF PATIENT WITH ACTIVE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN THE UNITED KINGDOM

    Nov 1, 2010, 00:00

  • PSS29 INTERNATIONAL CO-VALIDATION OF A NEW INTERNATIONAL QUALITY OF LIFE INSTRUMENT SPECIFIC TO PHYSICAL APPEARANCE- BEAUTYQOL

    Nov 1, 2010, 00:00

  • PIN72 BRAZILIAN STD/AIDS PROGRAMME- EXPENDITURE ON ANTIRETROVIRAL DRUGS AND EPIDEMIC INDICATORS DURING THE PERIOD 2004-2008

    Nov 1, 2010, 00:00

  • PCV6 OUTCOME OF ADVERSE DRUG REACTIONS REGISTERED WITH INTENSIVE MONITORING SYSTEM

    Nov 1, 2010, 00:00

  • PUK12 THE ECONOMIC IMPACT OF RENAL GRAFT FAILURE-A COST ANALYSIS IN A UK SETTING

    Nov 1, 2010, 00:00

  • PMS74 CLAIMS-BASED SEVERITY INDEX FOR RHEUMATOID ARTHRITIS FROM HEALTH CARE CLAIMS DATA

    Nov 1, 2010, 00:00

  • PIH50 MATERNAL MORTALITY RATE IN INDIA-A COMPREHENSIVE LITERATURE REVIEW

    Nov 1, 2010, 00:00

  • PHP77 DIRECT CONTRACTS ON PATENT-PROTECTED PHARMACEUTICALS IN GERMANY- MOTIVES OF SICK FUNDS AND PHARMACEUTICAL COMPANIES

    Nov 1, 2010, 00:00

  • PMH52 A SHORT 12-ITEM ZARIT BURDEN INVENTORY FOR THE ASSESSMENT OF DEMENTIA CAREGIVERS AS OBTAINED BY ITEM RESPONSE THEORY

    Nov 1, 2010, 00:00

  • PIN20 A MODELED ECONOMIC EVALUATION OF RALTEGRAVIR COMPARED TO STANDARD PRACTICE IN AUSTRALIA FOR TREATMENT NAVE PATIENTS WITH HIV

    Nov 1, 2010, 00:00

  • PGI21 RELATIONSHIP BETWEEN PATIENT PREFERENCES FOR 5-ASA THERAPIES AND SELF-REPORTED ADHERENCE

    Nov 1, 2010, 00:00

  • PMH20 SWITCHING BETWEEN SSRI BRANDS IN AUSTRALIA

    Nov 1, 2010, 00:00

  • CN1 EFFICACY OF THE COMBINATION BEVACIZUMAB PLUS CHEMOTHERAPY (BEV-CT) COMPARED TO CT ALONE IN PREVIOUSLY UNTREATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC)- SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA)

    Nov 1, 2010, 00:00

  • PSY28 COST OF INHIBITOR DEVELOPMENT IN PATIENTS WITH SEVERE HEMOPHILIA A IN SPAIN

    Nov 1, 2010, 00:00

  • PCN133 EPICLIN-LUNG STUDY- NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENT QUALITY OF LIFE AND HEALTH-STATE ASSESSMENT

    Nov 1, 2010, 00:00

  • PUK29 CHARACTERIZING THE RELATIONSHIP BETWEEN HEALTH UTILITY IN KIDNEY TRANSPLANT RECIPIENTS IN UK AND US WITH DIFFERENT LEVELS OF KIDNEY FUNCTION

    Nov 1, 2010, 00:00

  • PIH30 PERSISTENCE TO POSTMENOPAUSAL OSTEOPOROSIS (PMO) TREATMENTS IN A REGION OF SPAIN

    Nov 1, 2010, 00:00

  • PMH28 EFFECT OF PREGABALIN ON COSTS AND CONSEQUENCES IN PATIENTS WITH REFRACTORY SEVERE GENERALIZED ANXIETY DISORDER AND CONCOMITANT SEVERE SYMPTOMS OF DEPRESSION IN DAILY MEDICAL PRACTICE

    Nov 1, 2010, 00:00

  • PHP44 APPLICATION OF PERATOS PRINCIPLE TO UNDERSTAND COST DRIVERS IN HEALTH CARE

    Nov 1, 2010, 00:00

  • PSY7 AN ECONOMIC EVALUATION OF RECOMBINANT ACTIVATED FACTOR VIIA ROOM TEMPERATURE STABLE IN THE MANAGEMENT OF HEMOPHILIA PATIENTS WITH INHIBITORS IN SERBIA

    Nov 1, 2010, 00:00

  • RS2 PAYER ROADBLOCKS TO RISK-SHARING AGREEMENTS AROUND THE WORLD- WHERE, WHEN AND HOW?

    Nov 1, 2010, 00:00

  • PRS1 RISK OF SERIOUS ASTHMA EXACERBATIONS ASSOCIATED WITH LONG-ACTING-BETA-AGONISTS AMONG MEDICAID PATIENTS WITH ASTHMA-A RETROSPECTIVE COHORT STUDY

    Nov 1, 2010, 00:00

  • PMS1 HIGHER COMORBIDITIES IN PATIENTS WITH GOUT VS. WITHOUT GOUT IN THE US GENERAL POPULATION-THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES) 2007-2008

    Nov 1, 2010, 00:00

  • PRS11 A CASE STUDY EVALUATING MALAYSIAN COMMUNITY PHARMACISTS PROFESSIONAL PRACTICES AND SERVICES

    Nov 1, 2010, 00:00

  • PCV38 CLINICAL AND ECONOMICAL BENEFITS OF THE USE OF REMOTE MONITORING WITH CARELINK IN CENTRO MDICO NACIONAL 'LA RAZA', IMSS MEXICO

    Nov 1, 2010, 00:00

  • PIH3 A COSTING STUDY COMPARING MIDWIFERY GROUP PRACTICE WITH USUAL CARE IN AN AUSTRALIAN METROPOLITAN HOSPITAL

    Nov 1, 2010, 00:00

  • PCN47 CHANGE OF ANTIFUNGAL TREATMENT PATTERNS AND ASSOCIATED COSTS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) AFTER CHEMOTHERAPY IN A GERMAN HOSPITAL FROM 2004 TO 2006

    Nov 1, 2010, 00:00

  • PND10 LONG-TERM DISABILIY COST IN TUBEROUS SCLEROSIS COMPLEX (TSC) IN BRAZIL

    Nov 1, 2010, 00:00

  • PMS51 PATIENT PREFERENCES FOR SEVERE OSTHEOPOROSIS IN SPAIN- A DISCRETE CHOICE EXPERIMENT

    Nov 1, 2010, 00:00

  • PCV28 HEALTH-RELATED QUALITY OF LIFE AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROMES

    Nov 1, 2010, 00:00

  • PIN73 FACTORS AFFECTING THE DECISION TO RECEIVE VACCINATION FOR INFLUENZA VIRUS H1N1

    Nov 1, 2010, 00:00

  • PCN108 SOCIETAL COST SAVINGS ASSOCIATED WITH BEVACIZUMAB-BASED TREATMENT IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN ITALY

    Nov 1, 2010, 00:00

  • PCV4 EFFECT OF PRETREATMENT WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ON IN-HOSPITAL MORTALITY AFTER ACUTE ISCHEMIC STROKE

    Nov 1, 2010, 00:00

  • PMS56 DETERMINING THE OPTIMAL TIMING FOR TOTAL KNEE REPLACEMENT

    Nov 1, 2010, 00:00

  • PCV46 A SURVEY EXPLORING KNOWLEDGE AND PERCEPTIONS OF GENERAL PRACTITIONERS TOWARD THE USE OF GENERIC MEDICINES IN THE NORTHERN STATE OF MALAYSIA

    Nov 1, 2010, 00:00

  • PHP89 PERCEPTION OF PHARMACO-EPIDEMIOLOGICAL STUDIES BY PHYSICIANS AND MOTIVATION TO PARTICIPATE- FRENCH SITUATION

    Nov 1, 2010, 00:00

  • PCV44 EVALUATION OF CLINICAL AND DIRECT ECONOMIC OUTCOMES BETWEEN STATIN AND FENOFIBRATE AND STATIN MONOTHERAPY FOLLOWING AN INITIAL ACUTE CORONARY EVENT

    Nov 1, 2010, 00:00

  • PSY42 COST-EFFECTIVENESS ANALYSIS OF BIOLOGICS IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN THE PUBLIC HEALTH CARE SYSTEM OF BRAZIL

    Nov 1, 2010, 00:00

  • PCN165 INFLATION ANALYSIS AS A TOOL TO ASSESS COST-EFFECTIVENESS OF CANCER TREATMENT

    Nov 1, 2010, 00:00

  • PHP27 COMPARISON OF THE USE OF PRESCRIBED MEDICATIONS BETWEEN QUEBEC RESIDENTS COVERED BY PUBLIC AND PRIVATE DRUG INSURANCE-THE REMED REGISTRY

    Nov 1, 2010, 00:00

  • PCN21 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT HORMONAL TREATMENTS FOR POSTMENOPAUSAL HORMONE-RECEPTOR POSITIVE EARLY BREAST CANCER IN KOREAN CONTEXT

    Nov 1, 2010, 00:00

  • PHP74 PRIMARY HEALTH CARE AND POTENTIALLY AVOIDABLE ADMISSIONS-A 10-YEAR ASSESSMENT FROM THE PERSPECTIVE OF A HEALTH CARE PLAN

    Nov 1, 2010, 00:00

  • PRS29 COST-EFFECTIVENESS OF SALMETEROL/FLUTICASONE PROPIONATE COMBINATION VERSUS LEUKOTRIENE MONTELUKAST FOR THE CONTROL OF PERSISTENT ASTHMA IN CHILDREN

    Nov 1, 2010, 00:00

  • PIN14 COST-OF-ILLNESS OF CANDIDEMIA IN KOREA

    Nov 1, 2010, 00:00

  • PIH34 DRUG COST REDUCTION IN LONG-TERM CARE PATIENTS WITH CHRONIC DISEASE

    Nov 1, 2010, 00:00

  • PCN35 CLINICAL AND ECONOMIC IMPLICATIONS OF SCREENING FOR KRAS MUTATIONS IN METASTATIC COLORECTAL CANCER PATIENTS IN SPAIN- A COST-EFFECTIVENESS AND BUDGET IMPACT MODEL

    Nov 1, 2010, 00:00

  • PSY60 RESULTS FROM A COMPREHENSIVE LITERATURE REVIEW OF HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS)- MORE RESEARCH IS NEEDED?

    Nov 1, 2010, 00:00

  • BL4 COST-EFFECTIVENESS OF TREATMENT STRATEGIES FOR ANKYLOSING SPONDYLITIS- FIRST RESULTS OF A DISCRETE EVENT SIMULATION MODEL

    Nov 1, 2010, 00:00

  • PSS31 VISION-RELATED QUALITY OF LIFE INSTRUMENTS (QOL) AFTER REFRACTIVE CATARACT SURGERY

    Nov 1, 2010, 00:00

  • PMC25 STATISTICAL DISTRIBUTIONS OF COST DATA IN PROBABILISTIC SENSITIVITY ANALYSIS

    Nov 1, 2010, 00:00

  • PIH19 ETHNIC/RACIAL DIFFERENCE IN SELF-ASSESSMENT OF HEALTH STATUS IN THE GENERAL US POPULATION

    Nov 1, 2010, 00:00

  • PSY22 INDIRECT COSTS OF OBESITY IN POLAND

    Nov 1, 2010, 00:00

  • PCV87 USING VALUE OF INFORMATION ANALYSIS IN COMBINATION WITH AN EARLY STAGE MODEL OF COREVALVE FOR SEVERE AORTIC STENOSIS TO INFORM FUTURE RESEARCH NEEDS

    Nov 1, 2010, 00:00

  • PCN23 SIMULATION AND COMPARISON OF PROGRESSION-FREE-SURVIVAL OUTCOMES OF SEQUENTIAL TARGETED THERAPY IN METASTATIC RENAL-CELL CARCINOMA

    Nov 1, 2010, 00:00

  • PSS3 EPIDEMIOLOGY, COSTS AND QUALITY OF LIFE IN PATIENT WITH SEVERE CHRONIC HAND ECZEMA

    Nov 1, 2010, 00:00

  • PSY43 ECONOMIC ANALYSIS OF RITUXIMAB IN COMBINATION WITH CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA IN PORTUGAL

    Nov 1, 2010, 00:00

  • PUK5 COMPARISON OF SF-6D, EQ-5D AND VAS IN HEMODIALYSIS THAI PATIENT

    Nov 1, 2010, 00:00

  • PCV130 PRACTICE PATTERNS AND QUALITY OF LIFE IN ACUTE CORONARY SYNDROME PATIENTS IN 2008-2009- BASELINE RESULTS FOR AUSTRIA FROM THE ANTIPLATELET TREATMENT OBSERVATIONAL REGISTRY II (APTOR II)

    Nov 1, 2010, 00:00

  • PND25 ECONOMIC EVALUATION OF NATALIZUMAB IN THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN 4 EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PDB2 HOSPITALIZATIONS FOR SEVERE HYPOGLYCEMIAS IN PATIENTS WITH DIABETES MELLITUS IN SPAIN

    Nov 1, 2010, 00:00

  • PSY52 DEVELOPMENT AND CONTENT VALIDATION OF A MULTICENTRIC CASTLEMANS DISEASE SYMPTOM SCALE

    Nov 1, 2010, 00:00

  • PMS12 PROJECTION OF SURGICAL LOADS OF HIP AND KNEE

    Nov 1, 2010, 00:00

  • PCN15 SYSTEMATIC REVIEW OF LAPATINIB PLUS LETROZOLE WITH OTHER FIRST LINE TREATMENTS FOR HORMONE POSITIVE (HR ADVANCED OR METASTATIC BREAST CANCER (MBC)

    Nov 1, 2010, 00:00

  • PIN70 COST EQUITY ANALYSIS OF MALARIA MANAGEMENT-A PILOT STUDY IN THE AFRICAN SETTING

    Nov 1, 2010, 00:00

  • PCN88 COST-EFFECTIVENESS ANALYSIS OF CANCER TREATMENTS IN SOUTH OF IRAN

    Nov 1, 2010, 00:00

  • PHP87 THE ROLE OF VALUE OF INFORMATION ANALYSIS IN HEALTH CARE RESEARCH PRIORITY SETTING-A THEORETICAL CASE STUDY

    Nov 1, 2010, 00:00

  • PHP20 TRENDS IN DRUG EXPENDITURES IN SONGKHLA HOSPITAL

    Nov 1, 2010, 00:00

  • PUK20 THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE VS. SEVELAMER HYDROCHLORIDE IN PATIENTS WITH END-STAGE RENAL DISEASE

    Nov 1, 2010, 00:00

  • PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA

    Nov 1, 2010, 00:00

  • PCN21 FIRST-LINE BEVACIZUMAB-BASED THERAPY VERSUS PEMETREXED CISPLATIN FOR THE TREATMENT OF ADVANCED ADENOCARCINOMA NONSQUAMOUS NON-SMALL CELL LUNG CANCER- INDIRECT COMPARISON APPLYING REAL-LIFE OUTCOMES

    Nov 1, 2010, 00:00

  • PIH30 THE DRINKING BEHAVIOR OF RESIDENTS OF A VILLAGE IN AN INDUSTRIAL PARK AREA-THE CURRENT SITUATION AND REASONS BEHIND THIS BEHAVIOR

    Nov 1, 2010, 00:00

  • VA4 COST-EFFECTIVENESS OF UNIVERSAL HEPATITIS B IMMUNIZATION IN VIETNAM- APPLICATION OF COST-EFFECTIVENESS AFFORDABILITY CURVES IN HEALTH DECISION-MAKING

    Nov 1, 2010, 00:00

  • PIH61 CALIBRATION OF A DISCRETE EVENT SIMULATION MODEL OF NATURAL HISTORY OF HPV-RELATED DISEASES

    Nov 1, 2010, 00:00

  • PND5 BUDGET-IMPACT MODEL TO TEST EFFECTS OF CHANGING RUFINAMIDE TIER STATUS FROM A PAYER PERSPECTIVE

    Nov 1, 2010, 00:00

  • PND11 NURSE COSTING SURVEY FOR THE MANAGEMENT OF ADVERSE EVENTS IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH DISEASE-MODIFYING DRUGS IN THE UK

    Nov 1, 2010, 00:00

  • CE1 COST-EFFECTIVENESS ANALYSIS OF GLUCOSAMINE SULPHATE FOR THE TREATMENT OF OSTEOARTHRITIS IN THAILAND

    Nov 1, 2010, 00:00

  • PUK2 COMORBIDITY EFFECT ON HOSPITAL READMISSION RATES IN PATIENTS WITH RENAL FAILURE

    Nov 1, 2010, 00:00

  • PIH45 HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF FERTILE WOMEN USERS OF CONTRACEPTIVE METHODS

    Nov 1, 2010, 00:00

  • PCV20 COMPLIANCE WITH ANTIHYPERTENSIVE AGENTS AND THE ONSET OF END-STAGE RENAL DISEASE

    Nov 1, 2010, 00:00

  • PMH34 COST-EFFECTIVENESS ANALYSIS OF RISPERIDONE LONG-ACTING INJECTION IN SCHIZOPHRENIA- 24-MONTH DATA FROM CZECH REPUBLIC

    Nov 1, 2010, 00:00

  • PRS43 COMPLIANCE TO GOLD GUIDELINES IN THE TREATMENT OF COPD- APPROPRIATENESS AND POTENTIAL COST SAVING IN ITALY

    Nov 1, 2010, 00:00

  • PHP13 IMPLEMENTATION OF THE TRANSPARENCY DIRECTIVE IN HUNGARY

    Nov 1, 2010, 00:00

  • PCN95 A MARKOV MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF OMACETAXINE IN CHRONIC MYELOID LEUKEMIA

    Nov 1, 2010, 00:00

  • CN2 A SYSTEMATIC REVIEW AND META-ANALYSIS OF ADJUVANT CHEMOTHERAPY FOR STAGE III COLON CANCER

    Nov 1, 2010, 00:00

  • PHP72 ANALYSIS THE AVERAGE SOJOURN TIME AND BOTTLENECK AFTER A DISASTER IN HOSPITALS

    Nov 1, 2010, 00:00

  • PIN67 MODELING G-DRG REVENUE WHEN HOSPITALIZATION DURATION FROM CLINICAL TRIALS IS AVAILABLE-THE CASE OF DORIPENEM VERSUS IMIPENEM IN TREATING VENTILATOR-ASSOCIATED PNEUMONIA (VAP) IN GERMANY

    Nov 1, 2010, 00:00

  • PMS7 A COST-EFFECTIVENESS ANALYSIS OF OSTEOPOROSIS TREATMENT FOR FRACTURE PREVENTION IN POSTMENOPAUSAL THAI WOMEN- A COMPARISON OF SEVEN TREATMENT OPTIONS

    Nov 1, 2010, 00:00

  • PMS8 COST-EFFECTIVENESS OF RISEDRONATE FOR CORTICOSTEROID INDUCED OSTEOPOROSIS IN AUSTRALIA

    Nov 1, 2010, 00:00

  • PCV27 INCREASING PREVALENCE OF HYPERTENSION IN NIGERIA-A SYSTEMATIC REVIEW FROM 1990 TO 2009

    Nov 1, 2010, 00:00

  • PIN16 HEALTH CARE UTILIZATION AND COSTS ASSOCIATED WITH HEPATITIS A IN A US COMMERCIALLY INSURED POPULATION

    Nov 1, 2010, 00:00

  • PHP50 FRAGMENTED HEALTH CARE SYSTEM-SOLVING THE JIGSAW PUZZLE

    Nov 1, 2010, 00:00

  • PCN8 CLINICAL AND ECONOMIC BURDEN OF TOXICITIES ASSOCIATED WITH MONOCLONAL ANTIBODIES FOR METASTATIC COLORECTAL CANCER (MCRC)

    Nov 1, 2010, 00:00

  • PCN132 ERLOTINIB MAINTENANCE THERAPY FOR NON-SMALL CELL LUNG CANCER PRESERVES QUALITY OF LIFE

    Nov 1, 2010, 00:00

  • PDB20 OLDER WOMEN WITH DIABETES- CARDIOVASCULAR MEDICATION USE AND QUALITY OF LIFE

    Nov 1, 2010, 00:00

  • PND13 A PROSPECTIVE STUDY OF THE FINANCIAL COSTS OF MULTIPLE SCLEROSIS AT DIFFERENT STAGES OF THE ILLNESS IN IRAN

    Nov 1, 2010, 00:00

  • PIH53 DO HIGH-INCOME GROUPS IN PAKISTAN UNDERSTAND THE CONCEPT OF GENERIC MEDICINES?

    Nov 1, 2010, 00:00

  • PCV36 BUDGET IMPACT MODEL OF VENOUS THROMBOEMBOLISM PREVENTION AFTER TOTAL HIP AND KNEE REPLACEMENT

    Nov 1, 2010, 00:00

  • PDB2 LONG-TERM HEALTH OUTCOMES OF TREATMENT WITH LIRAGLUTIDE VERSUS GLIMEPRIRIDE IN TYPE 2 DIABETES PATIENTS IN ASIAN SETTING

    Nov 1, 2010, 00:00

  • PSS13 COSTS AND EFFECTS OF FIXED COMBINATION THERAPIES IN OPEN ANGLE GLAUCOMA

    Nov 1, 2010, 00:00

  • PCN44 COST COMPARISON OF ERLOTINIB VERSUS PEMETREXED FOR THE FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN SPAIN

    Nov 1, 2010, 00:00

  • PUK1 CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING COMPUTED TOMOGRAPHY- A COMPARATIVE SAFETY META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Nov 1, 2010, 00:00

  • PIN20 PSEUDOMONAS AERUGINOSA RELATED ECONOMIC BURDEN STRATIFIED BY COMORBIDITY IN CYSTIC FIBROSIS PATIENTS

    Nov 1, 2010, 00:00

  • PSY21 THE IMPACT OF COMORBIDITY ON INFLAMMATORY BOWEL DISEASE HEALTH COSTS

    Nov 1, 2010, 00:00

  • PCV34 DOES BALANCE BILLING RAISE THE CONCERNS ON EQUITY OF HEALTH UNDER A NATIONAL HEALTH INSURANCE PROGRAM IN TAIWAN?

    Nov 1, 2010, 00:00

  • PCN3 CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING EVENTS BY CHEMOTHERAPY EMETOGENICITY IN PATIENTS WITH CANCER TREATED IN A HOSPITAL OUTPATIENT SETTING

    Nov 1, 2010, 00:00

  • PMC61 MONITORING OF HEALTH ECONOMIC DATA IN CLINICAL TRIALS

    Nov 1, 2010, 00:00

  • PRS32 REGIONAL DIFFERENCES AS A BASIS FOR SENSITIVITY ANALYSIS OF COST-EFFECTIVENESS OF SALMETEROL FLUTICASONE PROPIONATE (SAL/FP) VS. INHALED CORTICOSTEROIDS (MONO-ICS)

    Nov 1, 2010, 00:00

  • PSY32 THE COST-EFFECTIVENESS OF ELTROMBOPAG FOR THE TREATMENT OF CHRONIC ADULT IMMUNE THROMBOCYTOPENIC PURPURA (ITP) IN IRELAND

    Nov 1, 2010, 00:00

  • PCN4 CANCER SYMPTOM SURVEY AND RELIABILITY ANALYSIS

    Nov 1, 2010, 00:00

  • PMS57 HEALTH-RELATED QUALITY OF LIFE AFTER TOTAL KNEE REPLACEMENT OR UNICOMPARTMENTAL KNEE ARTHROPLASTY IN AN URBAN ASIAN POPULATION

    Nov 1, 2010, 00:00

  • PIH65 USING A GENERALIZED ADDITIVE MODEL TO EXAMINE THE RELATIONSHIP BETWEEN BODY MASS INDEX AND HEALTH-RELATED QUALITY OF LIFE IN THE ELDERLY POPULATION-RESULTS FROM THE POPULATION-BASED GERMAN KORA-AGE STUDY

    Nov 1, 2010, 00:00

  • PMS14 RECURRENT FRACTURES AFTER FIRST HIP FRACTURES AND PREVENTION OF SECOND HIP FRACTURES IN JAPANESE WOMEN

    Nov 1, 2010, 00:00

  • PCV39 DOSE STATIN USE IN PATIENTS WITH DIABETES SAVE DOWNSTREAM RESOURCE UTILIZATION? A DIFFERENCE-IN DIFFERENCES ANALYSIS

    Nov 1, 2010, 00:00

  • PSY64 SEQUENCE OF TREATMENT IN IMMUNE THROMBOCYTOPENIA (ITP) PATIENTS- RESULTS OF A MEDICAL RECORD REVIEW FROM EIGHT HOSPITALS IN SPAIN

    Nov 1, 2010, 00:00

  • PMS3 THE RISK OF REFRACTURE ASSOCIATED WITH THE COMPLIANCE AND THE PERSISTENCE WITH BISPHOSPHONATE THERAPY IN TAIWAN

    Nov 1, 2010, 00:00

  • PIH37 DISPENSED MEDICATIONS LABELING IN MALAYSIA-VIEWS FROM GENERAL PUBLIC

    Nov 1, 2010, 00:00

  • MT3 COMPARATIVE EFFECTIVENESS OF ANTIDEPRESSANTS (AD) IN THE TREATMENT OF THE ELDERLY WITH MAJOR DEPRESSIVE DISORDER (MDD)-A MIXED TREATMENT COMPARISON AND META-REGRESSION ANALYSIS

    Nov 1, 2010, 00:00

  • PCV47 A NATIONAL SURVEY OF SOCIETAL COST OF ACUTE CORONARY SYNDROME IN SOUTH KOREA

    Nov 1, 2010, 00:00

  • PDB46 COST-EFFECTIVENESS OF NEW ANTIDIABETICS IN TYPE 2 DIABETES- A REVIEW

    Nov 1, 2010, 00:00

  • PMS11 LONGITUDINAL ASSESSMENT OF GOUT IN A LARGE SAMPLE OF ITALIAN PATIENTS- PREVALENCE AND DISEASE MANAGEMENT IN GPS OFFICES

    Nov 1, 2010, 00:00

  • PHP6 ROUTINE OF PATIENTS REDIRECTION IN THE HUNGARIAN PRIMARY CARE

    Nov 1, 2010, 00:00

  • PRS47 USE OF PROPENSITY SCORE MATCHING, STANDARD REGRESSION ANALYSIS AND INSTRUMENTAL VARIABLE METHOD IN OUTCOMES RESEARCH STUDIES- A COMPARATIVE ANALYSIS

    Nov 1, 2010, 00:00

  • PDB70 MEASUREMENT OF HRQOL USING EQ-5D IN TYPE 2 DIABETES MELLITUS PATIENTS TREATED WITH ORAL ANTI-DIABETIC DRUGS IN CHINA

    Nov 1, 2010, 00:00

  • HT3 COST-EFFECTIVENESS OF BLOOD PRESSURE LOWERING WITH A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN TYPE 2 DIABETES MELLITUS- A TRIAL-BASED ANALYSIS USING THE ADVANCE STUDY

    Nov 1, 2010, 00:00

  • PMS55 ANALYSIS ON THE POSSIBLE ASSOCIATION BETWEEN RHEUMATOID ARTHIRITIS AND DIABETES MELLITUS TYPE 2

    Nov 1, 2010, 00:00

  • PCV83 PILOTING THE DEVELOPMENT OF A COST-EFFECTIVE EVIDENCEINFORMED CLINICAL PATHWAY- MANAGING HYPERTENSION IN JORDANIAN PRIMARY CARE

    Nov 1, 2010, 00:00

  • PCV29 PREVALENCE, CHARACTERISTICS, AND IN-HOSPITAL OUTCOMES OF METABOLIC SYNDROME IN ACUTE CORONARY DISEASE PATIENTS IN OMAN

    Nov 1, 2010, 00:00

  • PCN34 USING DISCRETE CHOICE EXPERIMENTS TO ESTIMATE THE MARGINAL WILLINGNESS TO PAY OF INSURANCE PREMIUM FOR LIVER CANCER TREATMENT IN KOREA

    Nov 1, 2010, 00:00

  • PND36 HEALTH STATUS COMPARISON BETWEEN STABLE PARKINSONS DISEASE PATIENTS AND THOSE EXPERIENCING OFF-TIME

    Nov 1, 2010, 00:00

  • PCV25 RISK OF STROKE AND PREVENTATIVE STEPS AMONG PATIENTS DIAGNOSED WITH ATRIAL FIBRILLATION IN EUROPE

    Nov 1, 2010, 00:00

  • PHP92 COST-EFFECTIVENESS OF KNOWLEDGE TRANSLATION METHODS

    Nov 1, 2010, 00:00

  • PDB84 MANAGEMENT OF ACROMEGALY IN CLINICAL PRACTICE CONDITIONS IN SPAIN

    Nov 1, 2010, 00:00

  • PIN11 COST ANALYSIS OF ADVERSE DRUG EVENTS GROM GPO-VIRS AND GPO-VIRZ IN PEOPLE LIVING WITH HIV/AIDS IN THAILAND

    Nov 1, 2010, 00:00

  • PMS22 ECONOMIC BURDEN OF OSTEOPOROSIS-RELATED FRACTURE HOSPITALIZATIONS IN FRANCE

    Nov 1, 2010, 00:00

  • PCN147 MEDICAL RESOURCES UTILIZATION OF FIVE MOST PREVALENT CANCERS IN TAIWAN (LUNG CANCER, LIVER CANCER, COLORECTAL CANCER, GASTRIC CANCER, AND BREST CANCER)- 2001~2007

    Nov 1, 2010, 00:00

  • PCN83 A COST-EFFECTIVENESS ANALYSIS (CEA) FOR DENOSUMAB, A FULLY HUMAN MONOCLONAL ANTIBODY FOR CANCER TREATMENTINDUCED BONE LOSS (CTIBL) IN NON-METASTATIC PROSTATE CANCER (PRCA)- A SWEDISH PERSPECTIVE

    Nov 1, 2010, 00:00

  • PIN66 EVALUATION OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY IN MAITAMA DISTRICT HOSPITAL, ABUJA NIGERIA

    Nov 1, 2010, 00:00

  • PMS50 PATIENTS STATED HEALTH-OUTCOME PREFERENCES FOR CONFOUNDED PATIENT-REPORTED OUTCOME DOMAINS FOR OSTEOARTHRITIS

    Nov 1, 2010, 00:00

  • PHP4 POST HEALTH CARE REFORM PERCEPTIONS IN THE US- CONSUMER PULSE SURVEY

    Nov 1, 2010, 00:00

  • PCN121 CONFIRMATION OF BRIEF PAIN INVENTORY SHORT FORM (BPI-SF) 'WORST PAIN' ITEM CUT-POINT FOR THE ASSESSMENT OF PAIN PROGRESSION IN CASTRATION-RESISTANT PROSTATE CANCER (CRPC)

    Nov 1, 2010, 00:00

  • PMH13 COSTS ASSOCIATED WITH ANTIPSYCHOTIC MEDICATIONS FOR PATIENTS WITH A BIPOLAR DIAGNOSIS AT CLINICALLY RECOMMENDED DOSES

    Nov 1, 2010, 00:00

  • PHP86 SUCCESSFUL IMPLEMENTATION OF COVERAGE WITH EVIDENCE DEVELOPMENT SCHEMES- PRACTICAL EXPERIENCES IN SEVERAL WESTERN JURISDICTIONS

    Nov 1, 2010, 00:00

  • HT2 COST-EFFECTIVENESS OF INTERVENTIONS FOR REDUCING ROAD TRAFFIC INJURIES RELATED TO DRIVING UNDER THE INFLUENCE OF ALCOHOL

    Nov 1, 2010, 00:00

  • PSS4 COST-OF-ILLNESS IN PATIENTS WITH CHRONIC HAND ECZEMA- RESULTS FROM A MULTI-CENTRE STUDY IN GERMANY

    Nov 1, 2010, 00:00

  • PCN2 ASSESSMENT ON THE DECREASING USE OF NARCOTIC ANALGESICS BY USING CANCER PAIN ADJUVANTS

    Nov 1, 2010, 00:00

  • PHP130 TRENDS IN COST CONTAINMENT MEASURES

    Nov 1, 2010, 00:00

  • PIH8 ESTIMATED HEALTH AND ECONOMIC IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN THAILAND USING A TRANSMISSION DYNAMIC MODEL

    Nov 1, 2010, 00:00

  • PND12 EUROPEAN-HUNTINGTONS DISEASE BURDEN STUDY (EURO-HDB)-PRELIMINARY RESULTS FOR ITALY AND FRANCE

    Nov 1, 2010, 00:00

  • HE2 NEW DRUGS AND THE GROWTH OF HEALTH EXPENDITURE- EVIDENCE FROM DIABETIC PATIENTS IN TAIWAN

    Nov 1, 2010, 00:00

  • PCN25 COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB VERSUS DOCETAXEL AS A SECOND- OR THIRD-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN KOREA

    Nov 1, 2010, 00:00

  • PDB81 TIME TO ADD-ON MEDICATION USE FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) WHO FAILED METFORMIN MONOTHERAPY

    Nov 1, 2010, 00:00

  • PSS12 ECONOMIC EVALUATION OF RANIBIZUMAB IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION IN GREECE

    Nov 1, 2010, 00:00

  • PRS33 ECONOMIC EVALUATION OF ILOPROST, EPOPROSTENOL AND TREPROSTINIL FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

    Nov 1, 2010, 00:00

  • PIN53 COST-UTILITY ANALYSIS OF NEW PNEUMOCOCCAL CONJUGATE VACCINES IN THE REGIONAL IMMUNIZATION PROGRAM OF THE AUTONOMOUS REGION OF MADRID-IMPACT ON INVASIVE PNEUMOCOCCAL DISEASE

    Nov 1, 2010, 00:00

  • PCV61 ECONOMICS ESTIMATION OF SIDE EFFECTS CORRECTION ANTIHYPERTENSIVE MEDICAL PRODUCTS OF INHIBITORS-ACE IN RUSSIAN HEALTH

    Nov 1, 2010, 00:00

  • PCV55 HEALTH CARE UTILIZATION AFTER PLATELET AGGREGATION INHIBITORS

    Nov 1, 2010, 00:00

  • PCN123 DEVELOPMENT OF A COMPUTER-ADAPTIVE PATIENT REPORTED OUTCOME TOOL FOR THE SCREENING FOR PSYCHO-ONCOLOGICAL TREATMENT NEEDS

    Nov 1, 2010, 00:00

  • PHP96 SENSE OF COHERENCE-AS MEDIATING FACTOR IN REMAINING EMPLOYED IN HEALTH CARE PROFESSION

    Nov 1, 2010, 00:00

  • PHP121 INSPECTION OF THE PHARMACEUTICAL COMPANIES IN IRAN BY INSPECTION SOFTWARE

    Nov 1, 2010, 00:00

  • PMS10 HEALTH-CARE UTILIZATION OF NEW PATIENTS WITH LOW BACK PAIN IN SOUTH KOREA

    Nov 1, 2010, 00:00

  • PCV63 COST OF ABLATION PROCEDURES FOR ATRIAL FIBRILLATION- RESULTS FROM THE AIAC SURVEY

    Nov 1, 2010, 00:00

  • PCN20 MAINTENANCE ERLOTINIB VERSUS PEMETREXED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER- INDIRECT COMPARISON APPLYING REAL-LIFE OUTCOMES

    Nov 1, 2010, 00:00

  • PHP13 FACTORS ASSOCIATED WITH THE PROVISION OF LAPAROSCOPIC SURGERY IN THAILAND- RESULTS FROM THE NATIONWIDE INPATIENT DATABASE

    Nov 1, 2010, 00:00

  • PCV116 QUALITY OF LIFE IN CHRONIC SYMPTOMATIC HEART FAILURE PATIENTS IN SPAIN

    Nov 1, 2010, 00:00

  • PCV90 THE COST-EFFECTIVENESS OF ROSUVASTATIN VERSUS SIMVASTATIN FOR THE PREVENTION OF CARDIOVASCULAR MORBIDITY AND MORTALITY IN PATIENTS WITH HIGH BASELINE RISK-A SWEDISH ECONOMIC EVALUATION BASED UPON THE JUPITER TRIAL

    Nov 1, 2010, 00:00

  • PIH6 IMPACT OF ROTAVIRUS VACCINATION ON ACUTE GASTROENTERITIS RELATED EMERGENCY ROOM VISITS IN CHILDREN FIVE YEARS OLD IN BELGIUM

    Nov 1, 2010, 00:00

  • PCV23 EVALUATING THE BENEFITS WITH TELECARE AMONG RESIDENTS IN NURSING HOMES IN TAIWAN

    Nov 1, 2010, 00:00

  • PCN74 ADDING ZOLEDRONIC ACID TO ENDOCRINE THERAPY IN PREMENOPAUSAL WOMEN WITH HORMONE-RESPONSIVE EARLY BREAST CANCER CAN BE COST-EFFECTIVE FROM ITALIAN, SPANISH, AND PORTUGUESE HEALTH-CARE PERSPECTIVES, BASED ON THE ABCSG-12 TRIAL

    Nov 1, 2010, 00:00

  • PIH35 DEMONSTRATING CONCEPTUAL EQUIVALENCE ACROSS MULTIPLE CULTURES- TRANSLATION AND LINGUISTIC VALIDATION OF THE IPAQ

    Nov 1, 2010, 00:00

  • PMC18 MULTI-NATIONAL CHART REVIEW STUDIES IN EUROPE- OPPORTUNITIES AND CHALLENGES

    Nov 1, 2010, 00:00

  • PCN16 COST-EFFECTIVENESS ANALYSIS OF K-RAS TESTING AND CETUXIMAB FOR METASTATIC COLORECTAL CANCER IN JAPAN

    Nov 1, 2010, 00:00

  • PIN19 PHONED PILL REMINDER AND SELF-ADMINISTERED TREATMENT FOR TUBERCULOSIS CONTROL IN THAILAND- COST-EFFECTIVENESS

    Nov 1, 2010, 00:00

  • PCN106 INDIRECT COST IN NON-SMALL CELL LUNG CANCER (NSCLC)- A SYSTEMATIC LITERATURE REVIEW

    Nov 1, 2010, 00:00

  • PHP126 PATIENT ACCESS SCHEMES (PAS) IN THE UK COMING OF AGE-WHAT IMPACT WILL THEY HAVE ON OTHER EU COUNTRIES LIKE ITALY?

    Nov 1, 2010, 00:00

  • PHP129 ATTITUDES OF HUNGARIAN POPULATION TOWARD CO-PAYMENTS

    Nov 1, 2010, 00:00

  • PMC10 NONPARAMETRIC METHODS FOR VALUE OF INFORMATION ANALYSIS OF CLINICAL TRIALS

    Nov 1, 2010, 00:00

  • PCN50 BURDEN OF HOSPITALIZATIONS FOR HEPATOCELLULAR CARCINOMA PATIENTS IN A US POPULATION

    Nov 1, 2010, 00:00

  • PUK7 THE PHARMACY BUDGET IMPACT OF EXTENDING REIMBURSEMENT OF LANTHANUM CARBONATE TO TREATMENT OF HYPERPHOSPHATEMIA (1.78 MMOL/L) IN PATIENTS WITH CHRONIC KIDNEY DISEASE PRE-DIALYSIS IN FRANCE AND THE UNITED KINGDOM

    Nov 1, 2010, 00:00

  • PIN26 EARLY VS. LATE DETECTION OF HIV IN UK- COST CONSEQUENCE STUDY

    Nov 1, 2010, 00:00

  • PCN14 CLINICAL CONSEQUENCES OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY

    Nov 1, 2010, 00:00

  • PCN48 COST-EFFECTIVENESS COMPARISON OF APPROACHES FOR LOW-RISK PROSTATE CANCER CARE-THE NEED TO BALANCE COST AND UTILITY

    Nov 1, 2010, 00:00

  • PND18 48-HOUR INFUSION OF METHYLPREDNISOLONE IS A COST-EFFECTIVE INTERVENTION FOR TRAUMATIC SPINAL CORD INJURY

    Nov 1, 2010, 00:00

  • PIN6 A MULTIVARIATE MODEL- PREDICTORS OF DISEASE PROGRESSION IN HIV/AIDS PATIENTS IN WESTERN NEW YORK

    Nov 1, 2010, 00:00

  • PND15 PATIENT CHARACTERISTICS AND CHARGES ASSOCIATED WITH EMERGENCY DEPARTMENT VISITS AMONG PATIENTS WITH A DIAGNOSIS OF RESTLESS LEGS SYNDROME

    Nov 1, 2010, 00:00

  • PCN151 TARGETED CANCER THERAPIES- PRICING, ACCESS, AND UPTAKE

    Nov 1, 2010, 00:00

  • PUK6 POST RENAL TRANSPLANT PATIENT SURVIVAL AND THE COMBINED ADVERSE EFFECT OF POOR RENAL FUNCTION AND NEW ONSET DIABETES MELLITUS

    Nov 1, 2010, 00:00

  • PCN84 COST-EFFECTIVENESS OF ERLOTINIB IN FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN FIT ELDERLY PATIENTS- AN ECONOMICAL ANALYSIS OF A PROSPECTIVE PHASE 2 STUDY (GFPC 0504)

    Nov 1, 2010, 00:00

  • PDB36 LONG-TERM COST-CONSEQUENCE ANALYSIS OF EXENATIDE ONCE WEEKLY VERSUS SITAGLIPTIN OR PIOGLITAZONE IN TYPE 2 DIABETES PATIENTS IN THE UNITED STATES

    Nov 1, 2010, 00:00

  • PSY4 BIOLOGICAL AGENTS FOR THE TREATMENT OF NAIL PSORIASIS- A SYSTEMATIC REVIEW OF THE LITERATURE

    Nov 1, 2010, 00:00

  • PCV76 COST-EFFECTIVENESS ANALYSIS OF DRONEDARONE IN PATIENTS WITH ATRIAL FIBRILLATION IN MEXICO- A WITHIN TRIAL ANALYSIS BASED ON ATHENA TRIAL

    Nov 1, 2010, 00:00

  • PRS10 TRENDS IN ANTI-ASTHMA MEDICATION USE IN DUTCH CHILDREN FROM 1998 UNTIL 2007

    Nov 1, 2010, 00:00

  • PCN124 COMPUTER-ADAPTIVE TESTING OF FATIGUE IN ONCOLOGICAL PATIENTS

    Nov 1, 2010, 00:00

  • PHP94 IS IT COST-EFFECTIVE TO CHANGE THE BEHAVIOR OF HEALTH CARE PROFESSIONALS?

    Nov 1, 2010, 00:00

  • PCN142 WHAT IS THE CURRENT RD LANDSCAPE FOR METASTATIC BREAST CANCER? AN INVESTIGATION INTO RECENT CLINICAL TRIAL ACTIVITY

    Nov 1, 2010, 00:00

  • PHP112 ANALYSIS OF PHARMACISTS INTERVENTIONS OF ELECTRONIC PRESCRIPTIONS AT SULTAN QABOOS UNIVERSITY HOSPITAL IN OMAN

    Nov 1, 2010, 00:00

  • PIN30 ECONOMIC EVALUATION OF DAPTOMYCIN AS FIRST-LINE THERAPY VERSUS DAPTOMYCIN AS RESCUE THERAPY AFTER VANCOMYCIN OR LINEZOLID FAILURE IN GRAM-POSITIVE BACTEREMIA TREATMENT

    Nov 1, 2010, 00:00

  • PCN26 PHARMACOECONOMIC EVALUATION OF NILOTINIB IN TREATING TAIWAN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)

    Nov 1, 2010, 00:00

  • PCN18 ECONOMIC IMPLICATIONS OF THE FIRST-LINE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN THAILAND- A COST EFFECTIVENESS ANALYSIS

    Nov 1, 2010, 00:00

  • PND44 HEALTH RELATED QUALITY OF LIFE DEFICITS IN MULTIPLE SCLEROSIS-A POPULATION CONTROL ANALYSIS

    Nov 1, 2010, 00:00

  • PMS14 FACTORS INFLUENCED ORAL OXICAM AND COXIBS EXPENDITURE AT A THAI TEACHING HOSPITAL, FISCAL YEAR 2006-2009

    Nov 1, 2010, 00:00

  • PCV124 IMPACT OF REGIONAL MEASURES IN THE SALES OF THE RENINANGIOTENSIN SYSTEM ANTAGONISTS IN SPAIN

    Nov 1, 2010, 00:00

  • PIH36 ASSISTED REPRODUCTIVE TECHNOLOGIES- A HEALTH TECHNOLOGY ASSESSMENT PERSPECTIVE

    Nov 1, 2010, 00:00

  • BI2 MULTIPLE COHORT MODELING OF LONG-DURATION INTERVENTIONS- QUESTIONING TIME HORIZONS AND AGGREGATION ACROSS COHORTS

    Nov 1, 2010, 00:00

  • PIN65 IMPACT OF HERPES ZOSTER AND POSTHERPETIC NEURALGIA ON PATIENTS QUALITY OF LIFE

    Nov 1, 2010, 00:00

  • PCN12 EFFICACY OF SECOND LINE TREATMENTS IN PATIENTS WITH METASTATIC HORMONE REFRACTORY PROSTATE CANCER (MHRPC) IS NOT DEMONSTRATED BY PUBLISHED EVIDENCE FROM NONRANDOMIZED TRIALS

    Nov 1, 2010, 00:00

  • PMH13 ASSOCIATION OF MEDICATION PERSISTENCE AND HEALTH-CARE UTILIZATION IN HIGH-COST PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINE OR VENLAFAXINE XR

    Nov 1, 2010, 00:00

  • PIN39 COST-EFFECTIVENESS OF NUCLEIC ACID TEST SCREENING IN BLOOD DONATION FOR HIV IN BRAZIL

    Nov 1, 2010, 00:00

  • PSS16 ECONOMIC EVALUATION OF A 100 WHEY-BASED, PARTIALLY HYDROLYZED INFANT FORMULA IN THE PREVENTION OF ATOPIC DERMATITIS AMONG FRENCH CHILDREN

    Nov 1, 2010, 00:00

  • PIN13 BURDEN AND MEDICAL COSTS OF ANOGENITAL WARTS IN BANGKOK, THAILAND

    Nov 1, 2010, 00:00

  • PRS48 COMPARISON OF ECONOMETRIC MODELS FOR ESTIMATING COST DIFFERENCES- OLS, GAMMA, AND QUANTILE REGRESSION

    Nov 1, 2010, 00:00

  • NI4 DO PATIENT ACCESS SCHEMES RESULT IN AN ACCEPTABLE ADMINISTRATIVE BURDEN?

    Nov 1, 2010, 00:00

  • PIN41 ADAPTATION OF A TRANSMISSION DYNAMIC MODEL FOR THE QUADRIVALENT HPV VACCINE TO GERMANY

    Nov 1, 2010, 00:00

  • PCV37 POTENTIAL FOR PATIENT CONFUSION FROM BRAND SUBSTITUTION OF STATINS IN AUSTRALIA

    Nov 1, 2010, 00:00

  • PDB1 HYPOGLYCEMIA-RELATED HEALTH-CARE UTILIZATION FOLLOWING INITIATION OF INSULIN ASPART IN A VIAL/SYRINGE OR IN A PREFILLED DISPOSABLE PEN (FLEXPEN).ANALYSIS OF REAL-WORLD UTILIZATION IN THE UNITED STATES

    Nov 1, 2010, 00:00

  • PDB51 COST-EFFECTIVENESS OF EXENATIDE VERSUS INSULIN GLARGINE AND VERSUS BIPHASIC INSULIN ASPART FOR THE TREATMENT OF TYPE 2 DIABETES IN PORTUGAL- A LONG-TERM HEALTH ECONOMIC ANALYSIS

    Nov 1, 2010, 00:00

  • PCN59 COST OF MANAGEMENT OF BREAST CANCER WITH BRAIN METASTASES USING FRENCH HOSPITAL PATIENT CHAINING SYSTEM

    Nov 1, 2010, 00:00

  • PRS45 OPTIMIZATION OF GUIDELINES SUSTAINABILITY BY EVALUATING FACTORS PREDICTING TREATMENT RESPONSE IN PATIENTS WITH ALLERGIC RHINITIS

    Nov 1, 2010, 00:00

  • PMS64 CONSUMPTION OF BISPHOSPHONATES FOR THE TREATMENT OF OSTEOPOROSIS

    Nov 1, 2010, 00:00

  • PMH9 CHARACTERISTICS OF OUTPATIENTS INITIATED ON OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA IN JAPAN

    Nov 1, 2010, 00:00

  • PCV54 PATTERNS OF THERAPY, HEALTH CARE UTILIZATION, AND HEALTH CARE COSTS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) INITIATING THERAPY WITH SILDENAFIL- FINDINGS FROM RETROSPECTIVE ANALYSES OF ADMINISTRATIVE HEALTH CARE CLAIMS D ...

    Nov 1, 2010, 00:00

  • PDB6 PERFORMANCES OF COMORBIDITY MEASURES IN HEALTH CARERELATED BEHAVIORS AND OUTCOMES IN TYPE 2 DIABETES

    Nov 1, 2010, 00:00

  • PMS1 THE LONG-TERM UTILIZATION AND SAFETY OF BIOLOGICAL AGENTS IN TREATING RHEUMATOID ARTHRITIS PATIENTS-A POPULATION-BASED CASE STUDY IN SOUTHERN TAIWAN

    Nov 1, 2010, 00:00

  • PIN71 CLINICAL AND ECONOMIC BURDEN OF PEDIATRIC INFLUENZA IN NINE EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PMS79 USE OF PATIENT-REPORTED OUTCOMES IN ON-LINE COMMUNITIES TO CONDUCT OBSERVATIONAL COMPARATIVE EFFECTIVENESS RESEARCH- A PILOT STUDY IN RHEUMATOID ARTHRITIS

    Nov 1, 2010, 00:00

  • PGI2 A SYSTEMATIC REVIEW AND META-ANALYSIS OF LITERATURE ASSESSING CLINICAL EFFICACY OF TREATMENTS FOR PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B

    Nov 1, 2010, 00:00

  • DB1 EVALUATING THE COST-EFFECTIVENESS OF THERAPY CONVERSION FROM BASAL INSULIN TO BIPHASIC INSULIN ASPART 30/70 IN PATIENTS WITH TYPE 2 DIABETES IN CHINA- A MODELING STUDY OF LONG-TERM COSTS AND HEALTH OUTCOMES

    Nov 1, 2010, 00:00

  • PRS13 ECONOMIC IMPACT OF NON-ADHERENCE TO GOLD GUIDELINES IN COPD PATIENTS IN PRIMARY CARE IN SPAIN

    Nov 1, 2010, 00:00

  • PDB91 TREATMENT PATTERNS AND ACHIEVEMENT OF THERAPEUTIC GOALS IN A COHORT OF TYPE 2 DIABETES MELLITUS PATIENTS TREATED IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM (PHCS)- INITIAL REPORTS OF DIAPS 79 STUDY

    Nov 1, 2010, 00:00

  • PDB94 MARKOV AND MONTE-CARLO MODELS IN THE PROGRESSION OF DIABETES MELLITUS- A LITTERATURE REVIEW TO IDENTIIFY THE FACTORS INFLUENCING THE CHOICE OF THE TYPE OF MODEL

    Nov 1, 2010, 00:00

  • PCV68 POTENTIAL COST-EFFECTIVENESS OF A BIOMARKER TEST TO RECLASSIFY PATIENTS WITH AN INTERMEDIATE RISK BASED ON THE FRAMINGHAM RISK SCORE INTO A LOWER OR HIGHER CATEGORY TO OPTIMIZE STATIN THERAPY

    Nov 1, 2010, 00:00

  • PGI11 RISK FACTORS AND COSTS ASSOCIATED TO NSAIDS THERAPIES IN ITALY- AN ADMINISTRATIVE DATABASE ANALYSIS

    Nov 1, 2010, 00:00

  • PCN66 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED COLON-RECTUM CANCER IN CHINA

    Nov 1, 2010, 00:00

  • PHP107 ECONOMIC EVIDENCE REQUIREMENTS- COMPARISON BETWEEN HTA AGENCIES AND IMPLICATIONS FOR MANUFACTURERS

    Nov 1, 2010, 00:00

  • PMH8 EXCESS MORTALITY RISK IN PATIENTS WITH PSYCHOSIS HOSPITALIZED IN JAPANESE NATIONAL MENTAL HOSPITALS

    Nov 1, 2010, 00:00

  • PCN143 PRIMARY PREVENTION AS EXPANDED INDICATION TO MITIGATE COMPETITION-A CASE STUDY

    Nov 1, 2010, 00:00

  • PIH11 SOCIETAL IMPACT OF DIARRHEA IN YOUNG CHILDREN IN THE NETHERLANDS

    Nov 1, 2010, 00:00

  • PIN69 OUTPATIENT ANTIBIOTIC USE IN PRIMARY HEALTH CARE IN NIS REGION

    Nov 1, 2010, 00:00

  • PMH31 THE COST-EFFECTIVENESS OF ARIPIPRAZOLE IN PATIENTS WITH BIPOLAR I DISORDER IN THE UK

    Nov 1, 2010, 00:00

  • PDB90 IMPROVING PATIENT CARE- RESULTS FROM THE TEXAS NEWBORN SCREENING PERFORMANCE MEASURES PROJECT

    Nov 1, 2010, 00:00

  • PMS42 COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM

    Nov 1, 2010, 00:00

  • PHP103 NICE GUIDANCE-AN ANALYSIS OF LEVELS OF RESTRICTION BY DISEASE AREA

    Nov 1, 2010, 00:00

  • PCV3 COMPARISON OF MORTALITY, HEALTH CARE UTILITY AND COST OF PATIENTS WITH WARFARIN TREATMENT FOR NON-VALVULAR ATRIAL FIBRILLATION VERSUS PATIENTS WITH OTHER TREATMENT

    Nov 1, 2010, 00:00

  • PCN87 PHARMACOECONOMIC ANALYSIS OF DIRECT MEDICAL COSTS OF METASTATIC COLORECTAL CANCER THERAPY WITH XELOX OR FOLFOX4 WITH OR WITHOUT BEVACIZUMAB AS THE FIRST-LINE TREATMENT

    Nov 1, 2010, 00:00

  • PSY58 AVAILABILITY OF AND ACCESS TO ORPHAN DRUGS-AN INTERNATIONAL COMPARISON OF PHARMACEUTICAL TREATMENTS FOR PULMONARY ARTERIAL HYPERTENSION, FABRY DISEASE, HEREDITARY ANGIOEDEMA AND CHRONIC MYELOID LEUKEMIA

    Nov 1, 2010, 00:00

  • PSS7 THE ECONOMIC COST OF TREATING PATIENTS WITH AGE-RELATED MACULAR DEGENERATION IN SPAIN

    Nov 1, 2010, 00:00

  • PDB17 GLYCATED HEMOGLOBIN AS A SURROGATE MARKER FOR THE APPEARANCE AND PROGRESSION OF MACRO VASCULAR COMPLICATIONS IN TYPE 2 DIABETES MELLITUS- SYSTEMATIC REVIEW AND META-ANALYSIS

    Nov 1, 2010, 00:00

  • PRS49 TESTING THE USABILITY AND LANGUAGE OF E-PRO TRANSLATIONS DURING LINGUISTIC VALIDATION- COGNITIVE DEBRIEFING ON E-DEVICE VS. PRINT OUTSCREENSHOTS

    Nov 1, 2010, 00:00

  • PCN2 PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONISTS IN PREVENTING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENTS WITH CANCER TREATED IN A HOSPITAL OUTPATIENT SETTING

    Nov 1, 2010, 00:00

  • PIH7 ECONOMIC EVALUATION OF HUMAN PAPILLOMAVIRUS (HPV) VACCINATIONS IN THE PREVENTION OF CERVICAL CANCER

    Nov 1, 2010, 00:00

  • PIN14 PUBLIC HEATH AND ECONOMIC IMPACT OF ROTAVIRUS VACCINATION IN KOREA

    Nov 1, 2010, 00:00

  • PSY2 THE USE OF ETANERCEPT FOR TREATMENT OF PSORIASIS IN REAL CLINICAL PRACTICE-NON-INTERVENTION OBSERVATIONAL STUDY

    Nov 1, 2010, 00:00

  • PRS19 ASSESSMENT OF THE CLINICAL AND ECONOMIC IMPACT OF AIR LEAKS DURING POST-OPERATIVE PULMONARY SURGERY USING THE MEDICARE POPULATION

    Nov 1, 2010, 00:00

  • PMH16 THE ECONOMIC AND HUMANISTIC BURDEN OF ILLNESS IN GENERALISED ANXIETY DISORDER (GAD)- A RETROSPECTIVE DATABASE ANALYSIS IN EUROPE

    Nov 1, 2010, 00:00

  • PIH12 GOLD STAGE AND DURATION OF HOSPITAL ADMISSION DETERMINES SIZE AND STRUCTURE OF COPD RELATED DIRECT MEDICAL COSTS IN ELDERLY

    Nov 1, 2010, 00:00

  • PIN50 COST-EFFECTIVENESS OF PEGINTERFERON ALPHA-2A VERSUS PEGINTERFERON ALPHA-2B FOR TREATMENT OF CHRONIC HEPATTIS C INFECTION IN MEXICO

    Nov 1, 2010, 00:00

  • PSS34 THE IMPACT OF POTENTIAL PILL SPLITTING ON GENERIC AND BRANDED FINASTERIDE UPTAKE

    Nov 1, 2010, 00:00

  • PCN53 ANALYSIS OF SOCIOECONOMIC BUREDN OF HEPATOCELLULAR CARCINOMA IN RUSSIA

    Nov 1, 2010, 00:00

  • PIH33 PSYCHOMETRIC VALIDATION OF AN ABBREVIATED VERSION OF THE SEXUAL FUNCTION QUESTIONNAIRE (ASFQ)

    Nov 1, 2010, 00:00

  • PIN76 THE USE OF ECONOMIC ANALYSIS IN VACCINE EXPERT REVIEWS

    Nov 1, 2010, 00:00

  • PRS34 IMPROVED PREDICTION OF FINDING COPD PATIENTS BY LUNG FUNCTION PRE-SCREENING IN PRIMARY CARE

    Nov 1, 2010, 00:00

  • PSS30 DISCREPANCY IN PATIENT AND PHYSICIAN GLOBAL ASSESSMENTS OF DERMATOLOGIC DISEASES

    Nov 1, 2010, 00:00

  • PCN7 ESTIMATION ON THE INCIDENCE OF SELECTED CANCERS IN CHINA, 2004

    Nov 1, 2010, 00:00
  • «
  • 131
  • 132
  • 133
  • 134 (current)
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • »